| 0 (0%) | 04-26 21:05 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 41.09  |
1-year : | 44.41 |
| Resists | First : | 35.18 |
Second : | 38.02 |
| Pivot price | 32.72 |
|||
| Supports | First : | 30.57 | Second : | 25.44 |
| MAs | MA(5) : | 32.46  |
MA(20) : | 32.83 |
| MA(100) : | 27.16 |
MA(250) : | 23.19 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 36.4 |
D(3) : | 26.8 |
| RSI | RSI(14): 57.8 |
|||
| 52-week | High : | 39.9 | Low : | 17.38 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ CIX ] has closed below upper band by 24.5%. Bollinger Bands are 13% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 34.94 - 35.04 | 35.04 - 35.16 |
| Low: | 32.13 - 32.25 | 32.25 - 32.39 |
| Close: | 34.05 - 34.24 | 34.24 - 34.45 |
Wed, 31 Mar 2021
Cancer Genetics and StemoniX Announce Merger Closing - GlobeNewswire
Tue, 16 Feb 2021
Cancer Genetics Announces Closing of $17.5 Million Common Stock Offering Priced At-the-Market under Nasdaq Rules - Yahoo Finance
Tue, 25 Aug 2020
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact ... - AccessWire
Thu, 23 Apr 2020
The Lantern Pharma IPO Raises Some Questions - Nanalyze
Thu, 21 Nov 2019
These Penny Stocks Are Up Big This Month; Now What? - Penny Stocks
Thu, 14 Feb 2019
Could The Cancer Genetics, Inc. (NASDAQ:CGIX) Ownership Structure Tell Us Something Useful? - Yahoo Movies UK
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 12 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 87.7 (%) |
| Held by Institutions | 7.8 (%) |
| Shares Short | 33 (K) |
| Shares Short P.Month | 24 (K) |
| EPS | 1.67 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 13.4 |
| Profit Margin | 13 % |
| Operating Margin | 16.2 % |
| Return on Assets (ttm) | 8.1 % |
| Return on Equity (ttm) | 12.8 % |
| Qtrly Rev. Growth | -6 % |
| Gross Profit (p.s.) | 3.96 |
| Sales Per Share | 12.84 |
| EBITDA (p.s.) | 2.22 |
| Qtrly Earnings Growth | 16.8 % |
| Operating Cash Flow | 21 (M) |
| Levered Free Cash Flow | 15 (M) |
| PE Ratio | 20.39 |
| PEG Ratio | 0 |
| Price to Book value | 2.55 |
| Price to Sales | 2.66 |
| Price to Cash Flow | 20.53 |
| Dividend | 0.25 |
| Forward Dividend | 0 |
| Dividend Yield | 0.7% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|